The microbiome drugs market is emerging as one of the most transformative segments of the pharmaceutical and biotechnology industries. Driven by growing scientific understanding of the human microbiome and its role in health and disease, the market is witnessing rapid innovation and investment. The microbiome refers to the trillions of microorganisms living in and on the human body, especially...

According to The Insight Partners, the Microbiome Drugs Market is expected to register an impressive CAGR of 37.1% from 2025 to 2031, reflecting strong growth potential and increasing commercialization of microbiome-based therapies. The growing focus on personalized medicine and rising demand for advanced therapeutics are expected to drive market expansion significantly during the forecast...